Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The Canadian Optimal Therapy of COPD trial

Trial Profile

The Canadian Optimal Therapy of COPD trial

Phase of Trial: Phase III

Latest Information Update: 16 Jun 2006

At a glance

  • Drugs Tiotropium bromide (Primary) ; Salmeterol; Salmeterol/fluticasone propionate
  • Indications Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Acronyms OPTIMAL
  • Most Recent Events

    • 16 Jun 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top